Fiduciary Alliance’s MetLife MET Stock Holding History

Fiduciary Alliance’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,136	Closed	-$64.2K	–	629
2023 Q2	$64.2K	Buy	+1,136	New	+$63K	0.01%	277

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fiduciary Alliance's MET Position: Q3 2023 in Review

Fiduciary Alliance sold out of MetLife (MET) in Q3 2023, closing a stake of 1,136 shares — an estimated $64.2K sold.

Fiduciary Alliance first reported a position in MET in Q2 2023 and held it in 1 quarter. The position peaked at $64.2K in Q2 2023. 1,180 funds tracked by Wall St. Rank hold MET as of Q3 2023.

Fiduciary Alliance reported no remaining MetLife position as of Q3 2023 after selling out during the quarter.
Fiduciary Alliance sold 1,136 MetLife shares in Q3 2023, an estimated $64.2K.
Fiduciary Alliance first reported a position in MetLife in Q2 2023 and held it in 1 quarter.
Fiduciary Alliance's MetLife position peaked at $64.2K in Q2 2023.
1,180 funds tracked by Wall St. Rank held MetLife as of Q3 2023.

Based on Fiduciary Alliance's 13F filing for Q3 2023, filed 18 Oct 2023.